结直肠癌
阿柏西普
癌症研究
血管生成拟态
奥沙利铂
细胞迁移
细胞培养
生物
癌细胞
癌症
医学
免疫学
内科学
贝伐单抗
转移
遗传学
化疗
作者
Thouroude Sandrine,Patrick Van Dreden,Grigoris T. Gerotziafas,Annette K. Larsen
出处
期刊:Blood
[American Society of Hematology]
日期:2018-11-29
卷期号:132 (Supplement 1): 4974-4974
标识
DOI:10.1182/blood-2018-99-110202
摘要
Abstract Introduction. Cancer mortality is principally associated with the presence of drug-resistant, invasive subpopulations of tumor cells. However, the functional and mechanistic interactions between the two phenotypes are incompletely understood. Colorectal cancer (CRC) cells produce the vast majority of VEGF in the cancer environment and display endogenous VEGFR1/VEGF signaling which is believed to promoted survival under stress. Methods. Migration and invasion was determined by the transwell assay (Boyden Chamber). For the tube formation assay, CRC cells were seeded onto 3D matrigels and incubated at 37° for 24 hr monitored by videomicroscopy. Determination of VEGF ligands was carried out by ELISA. Results. We here characterize a panel of 4 isogenic CRC cell lines comprised of the parental HCT-116 cells and three independently derived sublines resistant to 5-fluorouracil, oxaliplatin and SN-38. Resistant cells secreted 3-7 fold more VEGF, while the HCT-116/5-FU cells also secreted 2 times more PlGF, compared to the parental cells. VEGF signaling is known to promote CRC cell migration and invasion. In agreement, resistant cells showed 6-11 fold increased migration, whereas the invasive capacity had increased 6-15 fold. Aflibercept inhibits all three VEGFR1 ligands (VEGF-A, VEGF-B and PlGF) on CRC cells accordingly, addition of aflibercept resulted in a significant decrease in both migration and invasion. Two of the three resistant cell lines were able to do vascular/vasculogenic mimicry by forming capillary-like cellular networks which could be significantly attenuated by aflibercept. Conclusions.Taken together, our results indicate that acquired resistance to genotoxic agents may be accompanied by an increased invasive potential mediated, in part, by VEGF signaling that can be attenuated by aflibercept. Disclosures No relevant conflicts of interest to declare.
科研通智能强力驱动
Strongly Powered by AbleSci AI